Molecule Details
| InChIKey | LUCFRFDOOYLALP-CYBMUJFWSA-N |
|---|---|
| Compound Name | (2R)-2-((4-fluoro-3-methylphenyl)sulfonylamino)-N-hydroxy-2-(tetrahydro-2H-pyran-4-yl)acetamide |
| Canonical SMILES | Cc1cc(S(=O)(=O)N[C@@H](C(=O)NO)C2CCOCC2)ccc1F |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.27 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
DrugBank Annotations
| DrugBank ID | DB07290 |
|---|---|
| Drug Name | (2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE |
| CAS Number | nan |
| Groups | experimental |
| ATC Codes | nan |
| Description | nan |
Cross-references: BindingDB: 8503 CHEMBL204593 ChemSpider: 3571962 PDB: 915 PubChem:4369384 PubChem:99443761 ZINC: ZINC000003818457
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P08253 | MMP2 | Homo sapiens | Human | PF00040 PF00045 PF00413 | Clinical | TTD_MultiTarget | TTD_MultiTarget |
| Q9ULZ9 | MMP17 | Homo sapiens | Human | PF00045 PF00413 PF01471 | Clinical | TTD_MultiTarget | TTD_MultiTarget |
| P15917 | lef | Bacillus anthracis | Pathogen | PF09156 PF07737 | 7.3 | IC50 | ChEMBL;BindingDB |
| P18843 | nadE | Escherichia coli (strain K12) | Pathogen | PF02540 | Clinical | TTD_MultiTarget | TTD_MultiTarget |
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P15917 | lef | Lethal factor | binder | targets |